CABA·12674W109·US·equity·Healthcare - Biotechnology-13D/G
CABA (CABALETTA BIO INC) is held by 65 institutional investors as of Q1 2026. Largest holders: JENNISON ASSOCIATES LLC ($24.1M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($23.8M), MILLENNIUM MANAGEMENT LLC ($15.9M). Net institutional sentiment: Mixed.
See how CABA's score breaks down across 4 SEC sources
Showing 1-20 of 73
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer